These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8429106)

  • 41. Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphoma.
    Giusti RM; Maloney EM; Hanchard B; Morgan OS; Steinberg SM; Wachter H; Williams E; Cranston B; Fuchs D; Manns A
    Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):699-704. PubMed ID: 8877061
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epitope analysis of the cerebrospinal fluid IgG in HTLV-I associated myelopathy patients using phage display method.
    Fujimori J; Nakashima I; Fujihara K; Feng J; Yamamoto M; Yamamoto N; Begum N; Sagara Y; Shiraki H; Shiga Y; Onodera J; Sato S; Takase S; Asano M; Endo M; Itoyama Y
    J Neuroimmunol; 2004 Jul; 152(1-2):140-6. PubMed ID: 15223246
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pulmonary involvement in patients with HTLV-I associated myelopathy.
    Mattos K; Melo A; Queiroz C; Publio L; Peçanha-Martins AC; Freitas V; Gomes I
    Arq Neuropsiquiatr; 1995 Dec; 53(4):766-70. PubMed ID: 8729770
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Significance of anti-HTLV-I antibody in cerebrospinal fluid in diagnosis of HTLV-I associated myelopathy (HAM)].
    Suehara M; Izumo S; Kumamoto I; Osame M
    Rinsho Byori; 1992 Mar; 40(3):311-6. PubMed ID: 1355573
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunological signature of the different clinical stages of the HTLV-1 infection: establishing serum biomarkers for HTLV-1-associated disease morbidity.
    Starling AL; Coelho-Dos-Reis JG; Peruhype-Magalhães V; Pascoal-Xavier MA; Gonçalves DU; Béla SR; Lambertucci JR; Labanca L; Souza Pereira SR; Teixeira-Carvalho A; Ribas JG; Trindade BC; Faccioli LH; Carneiro-Proietti AB; Martins-Filho OA
    Biomarkers; 2015; 20(6-7):502-12. PubMed ID: 26474234
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CSF-chemokines in HTLV-I-associated myelopathy: CXCL10 up-regulation and therapeutic effect of interferon-alpha.
    Narikawa K; Fujihara K; Misu T; Feng J; Fujimori J; Nakashima I; Miyazawa I; Saito H; Sato S; Itoyama Y
    J Neuroimmunol; 2005 Feb; 159(1-2):177-82. PubMed ID: 15652417
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The elevated interferon gamma production is an important immunological marker in HAM/TSP pathogenesis.
    Montanheiro PA; Penalva de Oliveira AC; Smid J; Fukumori LM; Olah I; da S Duarte AJ; Casseb J
    Scand J Immunol; 2009 Oct; 70(4):403-7. PubMed ID: 19751276
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative study of CSF neurofilaments in HTLV-1-associated myelopathy/tropical spastic paraparesis and other neurological disorders.
    Alberti C; Gonzalez J; Maldonado H; Medina F; Barriga A; García L; Kettlun A; Collados L; Puente J; Cartier L; Valenzuela M
    AIDS Res Hum Retroviruses; 2009 Aug; 25(8):803-9. PubMed ID: 19678766
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Extracellular matrix protein expression in cerebrospinal fluid from patients with tropical spastic paraparesis associated with HTLV-I and Creutzfeldt-Jakob disease.
    Cartier L; García L; Kettlun AM; Castañeda P; Collados L; Vásquez F; Giraudon P; Belin MF; Valenzuela MA
    Scand J Clin Lab Invest; 2004 Apr; 64(2):101-7. PubMed ID: 15115246
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Accumulation of human T-lymphotropic virus type I (HTLV-I)-infected cells in the cerebrospinal fluid during the exacerbation of HTLV-I-associated myelopathy.
    Hayashi D; Kubota R; Takenouchi N; Nakamura T; Umehara F; Arimura K; Izumo S; Osame M
    J Neurovirol; 2008 Oct; 14(5):459-63. PubMed ID: 18989817
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence of preferential female prevalence of HTLV-I associated tropical spastic paraparesis in Bahia-Brazil.
    Moreno-Carvalho OA; Santos JI; Di Credico G; Galvão-Castro B
    Arq Neuropsiquiatr; 1992 Jun; 50(2):183-8. PubMed ID: 1308388
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Specificity of intrathecal IgG synthesis for HTLV-1 core and envelope proteins in HAM/TSP.
    Kitze B; Puccioni-Sohler M; Schäffner J; Rieckmann P; Weber T; Felgenhauer K; Bodemer W
    Acta Neurol Scand; 1995 Sep; 92(3):213-7. PubMed ID: 7484074
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP): A comparative study to identify factors that influence disease progression.
    Matsuura E; Nozuma S; Tashiro Y; Kubota R; Izumo S; Takashima H
    J Neurol Sci; 2016 Dec; 371():112-116. PubMed ID: 27871430
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical and demographic features of HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Rio de Janeiro, Brazil.
    Araújo Ade Q; Alfonso CR; Schor D; Leite AC; de Andrada-Serpa MJ
    Acta Neurol Scand; 1993 Jul; 88(1):59-62. PubMed ID: 8372632
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
    Gessain A; Mahieux R
    Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cerebrospinal fluid neopterin, but not osteopontin, is a valuable biomarker for the treatment response in patients with HTLV-I-associated myelopathy.
    Nagai M; Tsujii T; Iwaki H; Nishikawa N; Nomoto M
    Intern Med; 2013; 52(19):2203-8. PubMed ID: 24088752
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: alternate molecular mechanisms underlying retroviral pathogenesis.
    Tendler CL; Greenberg SJ; Burton JD; Danielpour D; Kim SJ; Blattner WA; Manns A; Waldmann TA
    J Cell Biochem; 1991 Aug; 46(4):302-11. PubMed ID: 1757474
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pulmonary involvement in patients with human T lymphotropic virus type 1-associated myelopathy: the presence of specific IgA antibody in bronchoalveolar lavage fluid.
    Sugimoto M; Imamura F; Matsumoto M; Sonoda E; Cho I; Ando M
    Am J Trop Med Hyg; 1993 Jun; 48(6):803-11. PubMed ID: 8333573
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pathological and virological assessment of acute HTLV-I-associated myelopathy complicated with encephalopathy and systemic inflammation.
    Puccioni-Sohler M; Chimelli L; Merçon M; Gonçalves RR; Pimenta G; Bianco C; Rios M; Jacobson S
    J Neurol Sci; 2003 Mar; 207(1-2):87-93. PubMed ID: 12614936
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Up-regulation of interleukin-12 receptor expression in peripheral blood mononuclear cells of patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Fujimoto T; Nakamura T; Nishiura Y; Ichinose K; Furuya T; Shirabe S; Eguchi K
    J Neurol Sci; 2002 Apr; 196(1-2):21-6. PubMed ID: 11959151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.